Repare Therapeutics Inc.

NASDAQ:RPTX

1.32 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -93.796-29.047-106.908-53.417-27.216-14.283-7.796
Depreciation & Amortization 1.9511.9781.4710.8970.6050.4070.102
Deferred Income Tax 03.620.1490.588-0.6290.306-0.011
Stock Based Compensation 25.06319.69112.8292.5370.5110.3060.034
Change In Working Capital -55.1838.0254.7942.4216.588-0.4840.239
Accounts Receivables 0-1.5252.998-2.947-1.913-0.485-0.609
Inventory 00-2.9982.9471.91300
Accounts Payables 1.934-1.3480.1520.0170.8330.010.73
Other Working Capital -57.11710.8984.63842.4045.755-0.494-0.491
Other Non Cash Items -5.193-3.9451.8730.891.7121.131.425
Operating Cash Flow -127.1580.322-85.796-6.084-18.429-12.618-6.007
Investing Activities:
Investments In Property Plant And Equipment -1.938-0.602-1.69-2.237-1.304-0.583-1.156
Acquisitions Net 0175.1760.040000
Purchases Of Investments -179.021-256.576-7.476-7.526000
Sales Maturities Of Investments 25981.47.450000
Other Investing Activites 0-175.1760.014-7.526000
Investing Cash Flow 78.041-175.778-1.676-9.763-1.304-0.583-1.156
Financing Activities:
Debt Repayment 0000001.5
Common Stock Issued 0.8420.8894.288232.043103.243028.958
Common Stock Repurchased 0.6890.43300000
Dividends Paid 0000000
Other Financing Activities 0.8420.881.26915.799103.243028.958
Financing Cash Flow 0.8420.8895.557247.842103.243030.458
Other Information:
Effect Of Forex Changes On Cash 0.022-0.33-0.054-0.6040.566-0.2590.007
Net Change In Cash -48.253-174.9068.031231.39184.076-13.4623.302
Cash At End Of Period 111.268159.521334.427326.39695.00510.92924.389